GASTROINTESTINAL LOW FAT + HYPOALLERGENIC

Rice flour*, hydrolysed soya protein isolate**, rice*, beet pulp, hydrolysed poultry liver**, animal fats, minerals, psyllium husks and seeds, fish oil, sodium butyrate, soya oil, fructo-oligosaccharides (0.48%), marigold meal. *Carbohydrate sources: 51.6%. Highly digestible ingredients: 79.1%. **Protein sources: 23.3%.

Nutritional additives: Vitamin A: 34000 IU, Vitamin D3: 800 IU, Vitamin E: 660 mg, Vitamin C: 260 mg, Taurine: 1.9 g, Iron (3b103): 39 mg, Iodine (3b201, 3b202): 3.5 mg, Copper (3b405, 3b406): 14 mg, Manganese (3b502, 3b504): 51 mg, Zinc (3b603, 3b605, 3b606): 152 mg, Selenium (3b801, 3b811, 3b812): 0.24 mg Technological additives: Clinoptilolite of sedimentary origin: 10 g - Preservatives - Antioxidants. Values reflect only levels added to the formula, not those naturally occurring in components of the diet.

ANALYTICAL CONSTITUENTS: Protein 25%, Fat 7%, Calcium 0.8%, Phosphorus 0.6%, Ash 6.2%, Crude Fibre 1.3%, Moisture 9.5%, EPA/DHA 0.15%.

FEEDING INSTRUCTIONS: see table. Water should be available at all times. Batch number, factory registration number and best before date: see information on packaging. To be stored in a cool, dry place.

LEGAL NOTICE: Expiration date: Displayed at the bottom of the bag (date/month/year) - Manufacture date: 18 months before the expiration date - Manufacturing country & source: France, ROYAL CANIN SAS France - Net weight: Separately declared on the bag

ROYAL CANIN® GASTROINTESTINAL LOW FAT + HYPOALLERGENIC dry is a complete dietetic feed for dogs, formulated for the support of lipid metabolism in the case of hyperlipidaemia and for the reduction of ingredient and nutrient intolerances. Low level of fat. Hydrolysed protein sources and selected carbohydrate sources. RECOMMENDATIONS: It is recommended that a veterinarian's opinion be sought before use and before extending the period of use. Feed GASTROINTESTINAL LOW FAT + HYPOALLERGENIC dry for 3 to 8 weeks: if signs of intolerance disappear this feed can be used initially up to one year, and initially up to 2 months for the support of lipid metabolism in the case of hyperlipidaemia.